Anemia and Kidney Disease
Anemia and Kidney Disease
Part of NephTimes
Advertisement
Charlotte RobinsonAnemia and Kidney Disease | March 28, 2024
The FDA approved Vafseo (vadadustat) to treat anemia due to chronic kidney disease (CKD) in adults on dialysis.
Read More
Charlotte RobinsonAnemia and Kidney Disease | March 22, 2024
SGLT2 inhibitors have benefits for anemia risk but their effectiveness among patients with T2D and CKD stage 1-3 was unclear.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients with early chronic kidney disease (CKD) frequently develop anemia.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
In multivariate logistic regression analysis, a higher UFR was associated with lower hemoglobin levels.
Dr. Richard LafayetteChronic Kidney Disease | February 5, 2024
Dr. Richard Lafayette discusses the FDA approval of TARPEYO, which reduces the loss of kidney function in IgA nephropathy.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
The primary efficacy end point of interest was the mean change in hemoglobin from baseline over weeks 12 to 16.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients with chronic kidney disease (CKD) commonly develop anemia.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Trials included in the analysis compared HIF-PHIs to placebo or to erythropoiesis-stimulating agents (ESA).
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients receiving maintenance hemodialysis who develop anemia are commonly treated with erythropoiesis-stimulating agents.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients with end-stage kidney disease with anemia are commonly treated with recombinant human erythropoietin.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
There are associations between anemia in ESKD and increased risk of morbidity and mortality.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Interpatient variation in mean hemoglobin levels were smaller in the intervention arm than in the standard of care arm.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
The results suggested that treatment with HIF-PHIs increased the level of hemoglobin.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
One of the most common complications of chronic kidney disease (CKD) is renal anemia.
Cailin ConnerAnemia and Kidney Disease | February 5, 2024
Extended storage of red blood cells correlated with increased transplant longevity following kidney transplant.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
There were no differences seen in adverse events and serious adverse events among trial participants.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
There were no statistically significant differences between the two groups in eGFR and proteinuria slopes.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
There was a strong association between lower eGFR and increased prevalence of anemia across all categories of hemoglobin.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Potential benefits and risks associated with treatment with HIF-PHIs for patients with anemia of CKD.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients with chronic kidney disease (CKD) frequently experience anemia, a common complication associated with increased ...
Advertisement
Advertisement
Advertisement
Latest News

April 19, 2024